Then qPCR and Western blotting revealed that Se-Met supplementation reduced the production of ADAMTS-5 and MMP-13 and promoted the secretion of Aggrecan and Col-2 in response to mechanical overloading, while additional ML210 aggravated ECM metabolic disorder (Fig. 4K–M). The gene discussed is MMP13; the disease is metabolic disease.